June 5, 2026 · AstraZeneca
AstraZeneca Advances Peptide Innovation to Tackle Undruggable Targets
AstraZeneca is pioneering innovative peptide strategies to address previously undruggable targets in drug development.

The latest peptide research, clinical findings, and industry updates — curated and summarized for researchers.
June 5, 2026 · AstraZeneca
AstraZeneca is pioneering innovative peptide strategies to address previously undruggable targets in drug development.
June 3, 2026 · Medical Xpress
An experimental peptide therapy has demonstrated preclinical efficacy, revealing a potential new target for treating metastatic breast cancer.
June 1, 2026 · KevinMD.com
Peptide therapy is gaining attention, but understanding the clinical evidence and its implications is crucial for researchers.